Additionally, understanding the role of C3aR in regulating secondary bacterial infections during viral infections, a clinical manifestation common in pandemic respiratory viruses such as SARS-CoV-2 [58–60], may prove beneficial to developing therapeutics for future viral pandemics. This evidence concerns the gene C3AR1 and bacterial infectious disease.